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Summary: The "alkaline haematin D-575" method for determining haemoglobin, described by Zander et al.
((1984) Clin. Chim. Acta 136, 83 — 93) was tested. Claims that different non-ionic detergents in the reagent
result in identical values for the haemoglobin concentration being measured could not be verified. It could
also not be verified that a stable end-product with unique spectral characteristics is always reached within
approximately 2 min and that conversion of fetal haemoglobin is faster than that with the haemiglobin
cyanide method. Because of the many questions regarding the nature and characteristics of the alkaline
haematin/detergent complex or complexes, it is not yet possible to recommend this method for routine
haemoglobinometry.
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 imprecision must be stated.
The best-studied method in the clinical haematology
') The use of trade names is for Identification only and does laboratory is undoubtedly the spectrophotometric
not constitute endorsement by the PubHc Health Service or
 measurement of haemoglobin in human blood after
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a memberof the ICSH Expert Panel on Haemoglobinometry. (HiCN; cyanmethaemoglobin). Review of the litera-
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ture, äs well äs results of extensive measurements, led
the ICSH Expert Panel on Haemoglobinometry to
formulate Recommendations for Haemoglobinome-
try in Human Blood in 1967 (3).
Every standardized method and all Standards used
must be continually critically evaluated and must not
become static. If necessary, recommendations must
be added to or eased, and new, proven techniques
should be employed for preparation and checking of
Standards äs they become available. This process is
referred to äs dynamic standardization. Accordingly,
the Expert Panel on Haemoglobinometry has care-
fully monitored the literature on haemoglobinometry,
organized symposia (4, 5), and revised the original
recommendations in 1977 and 1987 (6, 7).
The Reference Method
The ICSH-recommended HiCN method was devel-
oped in the nineteen sixties after the redetermination
of the (milli)molar absorptivity of HiCN at 540 nm,
^ , based pn exhaustive haemoglobin-iron analyses
(8, 9). The value measured has since been verified by
various other methods, including N and C analyses,
and X-ray emission spectrography (10). Statistical
analysis of the published data allows us to state with
confidence that eS&N = 10.99 ± 0.011 - mmor1 -
cm""1 (corresponding to 1099 + l m2 · mol"1) (x +
Standard error of the mean), n = 521 (l 1). As the
HiCN method has become increasingly used
throughout the world, certain limitations have been
described and accepted by the clinical laboratory
Community, e. g., loss of CN~~ from the reagent on
storage, reagent instability on freezing, nonconversion
of sulphaemoglobin to HiCN, increased reaction time
required to convert carboxyhaemoglobin, HbCO, to
HiCN (12-16). Review and revision of ICSH
recommendations have taken these fmdings into
account and include appropriate warnings in the
description of the reference method. It is evident that
the HiCN method meets the ICSH defmition of a
reference method: "a clearly and exactly described
technique" with a stated degree of inaccuracy and
imprecision.
An Alternative Proposal
In 1984, Zander, Lang & Wolf described a method to
measure haemoglobin photometrically after conver-
sion to an alkaline haematin/detergent complex,
which they called alkaline haematin D-575, abbrevi-
ated "AHD" (17). The authors describe their method
äs being "extremely stable," "rapid and accurate,"
"superior to the reference method" with the possibility
of "direct standardization by a solid Standard, stable
in crystalline and dissolved form" that "can be han-
dled easily for weighing" (18). The authors conclude
that their method "meets the recommendations of the
World Health Organization better than the conven-
tional cyanhaemiglobin method" and question "which
of the methods should be preferred in the future."
Members of the ICSH Expert Panel on Haemoglo-
binometry, individually and cöllectively, have re-
viewed the method and have concluded that, although
it has some merit, it canüot be considered a viable
candidate for reference method Status.
The reagent: Zander et al. report that "practically the
same results are obtained when Triton X-100 concen-
tration is varied between 10 and 50 g/l or when NaOH
concentration is varied between 0.01 and 1.0 mol/U
or when Triton X-100 is replaced by other non-ionic
detergents ..." This was tested by preparing three 0.1
mol/1 NaOH Solutions per litre containing 25 g Triton
X-100, 25 g Siponic 218 (PEG-10 isolauryi thioether),
and 25 g Sterox SE (alkylphenol(thiol) polyethylene
oxide), respectively. With these three reagents, the
haemoglobin concentration of 11 normal blood spec-
imens was determined and compared with that meas-
ured äs HiCN (100 sample plus 25 ml HiCN re-
agent). The Triton X-100-containing reagent gave a
mean difference of + 1.54 g/l (ränge —2.7 to + 4.7
g/l; Standard deviation of the difference, SDd, 1.97
g/l), the Siponic 218-containing reagent a mean dif-
ference of -0.6 g/l (ränge -4.1 to +2.2 g/l; SDd,
1.66 g/l), and the Sterox SE-containing reagent a
mean difference of —0.04 g/l (ränge —3.5 to -h 2.1
g/l; SDd, 1-52 g/l). All measuremeiits were perfqnned
on a properly calibrated Varian Cary 219 spectropho-
tometer with appropriate blanks.
The endproduct, alkaline haematin/detergent complex:
Zander et al. report that "alkaline haematin D-575"
is characterized by a unique absorbance spectrum that
is not influenced by the type of starthig material (e. g.,
haematin, fresh human blood). Careful inspection of
the authors' figure 2 (17), however, clearly shows
differences, especially around 535 nm (absorbance
minimum), between the end product obtained from
freshly prepared haemin (chlorohaemin, a term used
extensively in the German literature [19]), a year-old
solution, and freshly drawn blood. We observed spec-
tral changes of a blood/NaOH-Sterox SE mixture
over a period of 48 h, especially around the absorb-
ance minimum (535 nm) and the shoüldef airoünd 600
nm (fig. 1), although the absorbance at 575 nm, A
575 nm, changed little during that period.
,;
Zander et al. report that the (milli)molar absorptivity
at 575 nm of alkaline haematin D-575 was 6.960
± 0.0461 - mmol"1 · cm"1 (corresponding to 696.0
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Fig. 1. Absorbance curves of 20 μΐ fresh blood diluted with
3 ml reagent containing 0.1 mol NaOH and 25 g Sterox
SE per liter. Curves recorded with a Varian Cary 219
spectrophotometer against the reagent blank 3 h after
preparation (curve 1), 18h after preparation (curve 2),
and 48 h after preparation (curve 3).
± 4.6m2 · mol"1) (n = 24) when 12 haematin
preparations were measured on two different days.
When this value for 575 mn was used to calculate the
haemoglobin coneentration of blood samples, a
systematic bias of 2.6% was found compared with
results obtained with the HiCN method. The authors
speculate that the cause of the bias could be that the
1100 m2 · mol"1) is erroneous. However, it should be
taken into consideration that:
(1) the value of ε?παΝ has been determined over a
period of nearly two decades by more than 10 inde-
pendent investigators using equine and human whole
blood, washed red cells, and purified haemoglobin
Solutions, with various iron analyses, including X-ray
emission spectrography, with N and C analyses, and
with a titrimetric method (20), encompassing a total
of 521 determinations (10, 11);
(2) the authors' value of 575 nm is based on 12
samples of one type of material (recrystallized hae-
min) for which they provide no data on purity s
determined by independent chemical assays; and
(3) there is no guarantee that their corresponding
haemoglobin determinations with the HiCN method
were correct, s commercial reagents and Standards
were used (Boehringer, Merck) that in the past have
given erroneous results (21).
Zander et al. claim that a "strong linear dependence"
exists between the coneentration of alkaline haematin
D-575 and absorbance. Careful inspection of their
data (I.e. (18), table 2) suggests, however, increasing
alinearity with decreasing coneentration below 6.6
χ 10~2 mmol/1 and some alinearity with increasing
concentration above 8.2 χ 10~2 mmol/1 (tab. 1;
fig. 2).
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Fig. 2. Measured absorbance (dashed line) of "alkaline haematin D-575" dilutions of a 10 mmol/1 haemin stock solution plus
3 ml NaOH^Triton X-100 reagent, compared with the calculated absorbance (solid line) based on 8575 nm = 6.961 · mmol !
• cm"1 (= 696 m2 · mol-1). Data from table 2, I.e. (18).
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Tab. 1. Calculated (bascd on (müli)molar absorptivity = 6.961 Conclusions
mmol'1 · cm"1 (= 696m2 · mol"1)) and measured
absorbance of "alkaline haemalin D-575" Solutions.
Data from I.e. (18).
Haemalin
(10~2 ramol/1)*
1.66
3.32
4.975
6.62
8.26
9.90
13.16
16.39
Absorbance
caiculated
0.116
0.231
0.346
0.461
0.575
0.689
0.916
1.141
measured
0.123
0.236
0.351
0.461
0.575
0.679
0.899
1.116
Deviation from
caiculated ab-
sorbance (%)
+6.0
4-2.2
+ 1.45
0
0
-1.45
-1.8
-2.2
*) Multiply by 10 to obtain /
Method-related errors: Zander et al. stated in their
first publication (17) that "all haemoglobin species
with clinical significance converted into one single end
product" and recently published a paper on plasma,
cell ghost, leukocyte, and haemoglobin errors (22) in
which they claim that the HiCN method overestimates
the haemoglobin concentration of fetal haemoglobin
(HbF)-contairiing blood by 0.4% to 0.7% when meas-
uring 3 to 5 min after mixing blood and reagent. With
the alkaline haematin/detergent method, the overes-
timation was reported to be no greater than 0.1%.
We studied the conversion time of HbF with three
cord-blood specimens from premature infants, birth
weight about 1200, 1200, and 800g. The HbF frac-
tion, measured with an alkali denaturation method
(23), was 0.65, 0.77, and 0.79. The samples were
diluted with NaOH-Triton X-100 (highly purified,
Boehringer, cat. No. 789704) reagent and measured
at 575 nm (bandpass 2 nm) every 5 s for 10 min with
an HP 8451A diode array spectrophotometer cali-
brated äs to wavelength and absorbance, with absence
of stray light verified. The percent decrease in A 575
nm from t = 5 after initial mixing is summarized in
table 2. Neither HbF nor normal HbA reached a
stable value of A 575 nm during the 10 min that the
reaction was followed. This may have been caused by
insufficient "maturing" (18) of the reagent, which had
been prepared only 24h before use. After dilution
with HiCN reagent, a stable A 540 nm reading was
obtained after 3.5 and 4min for sample HbF 3 and
HbF l and 2, respectively.
Before any analytical System is implemented in a
clinical laboratory, it must be validated by that lab-
oratory, i.e., the laboratory must determine to its
satisfaction that the System provides results äs good
or better than those given by the method already in
routine use. Before any analyticaj System can acquire
the Status of selected or reference method, it must
have been validated by one or more cooperative stud-
ies and be recommended by a defined authority. At
least one attempt at validation of the "AHD" method
has not yet been successful and has raised a number
of questions, including:
1. What is the exact nature of the alkaline haematin/
detergent complex? Is the same complex obtained
when different starting materials are used, e.g.,
haemin, haematin, purified haemoglobin Solutions,
washed erythrocytes, fresh whole blood, and when
different non-ionic detergents are used? Whät is
the trüe (rnilli)molar absorptivity of the complex
or complexes?
2. Can freshly prepared hydroxide/detergent reagents
be used, or do they have to "mature"? If so, what
is the nature of the "maturation" process?
3. What results are obtained when the alkaline hae-
matin/detergent method is compared with the
HiCN reference method in a number of independ-
ent laboratories using HiCN Standards and re-
agents of ICSH^recommended purity and compo-
sition?
With satisfactory answers to these questions, the al-
kaline haematin/detergent method could become an
ICSH "selected method" or, äs an extensive database
on the method becomes available, a candidäte for
reference method. However, for a new method tö
replace an existing one äs reference, distinct advan-
tages and more than marginal improvement must be
demonstrated. Because of the vast expefience with the
HiCN method, the large body of experimental work
cömprising every detail of the procedure, the well-
functioning network of laboratories monitoring the
International Reference Standards on the one band
Tab. 2. Percent decrease from initial value of A 575 nm with time when cord blood specimens were mixed with NaOH/Triton
X-100 reagent.
Time (s)
Sample
HbFl
2
3
HbA (normal)
5
0
0
0
0
60
3.2
2.6
3.3
1.4
120
5.3
5.1
5.7
2.4
180
6.9
7.5
7.4
2.9
240
8.1
7.7
8.8
3.4
300
9.6
8.5
10.3
3.9
360
12.3
9.4
11.7
6.1
420
11.2
10.4
12.4
6.0
480
12.9
11.2
13.4
5.6
540
14.1
12.1
14.6
6.7
600
15.3
12.8
15.5
7.5
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and the great effort and long time necessary to achieve
worldwide standardization of any clinical laboratory
procedure on the other, extreme care should be taken
and very clear advantages should be within reach
before the current reference System for haemoglobi-
nometry can be challenged.
Reported advantages of the "AHD" method are the
smaller influence of turbidity by plasma cornponents
and erythrocyte ghosts, obviously the result of the
more alkaline reagent solution, and the shorter con-
version time, especially with carboxyhaemoglobin.
Except with such a degree of hyperlipaemia detectable
by even an average laboratory technician, the im-
provements obtained are only marginal. The authors
(22) have measured a "normal plasma error," ex-
pressed äs absorbance, of 0.005 for the HiCN method,
compared with 0.003 for the "AHD" method but fail
to provide data on the probable traces of plasma
haemoglobin in the 14 samples studied. The improve-
ment gained with respect to an erythrocyte ghost error
is less than marginal: 0.0015 with the HiCN method
compared with 0.0010 with the "AHD" method; num-
ber of samples studied is not given. Finally, a carboxy-
haemoglobin error in the HiCN method will only
become clinically significant when the fraction ofcarb-
oxyhaemoglobin is high enough to cause clear clinical
signs of carbon monoxide poisoning (l 2).
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